[HTML][HTML] Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)
Scope Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has
become pandemic, reaching almost one million death worldwide. At present standard …
become pandemic, reaching almost one million death worldwide. At present standard …
Cardiovascular considerations in treating patients with coronavirus disease 2019 (COVID-19)
DL Dixon, BW Van Tassell, A Vecchie… - Journal of …, 2020 - journals.lww.com
A novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
has spread rapidly across the globe since December 2019. Coronavirus disease 2019 …
has spread rapidly across the globe since December 2019. Coronavirus disease 2019 …
[HTML][HTML] COVID-19: review of epidemiology and potential treatments against 2019 novel coronavirus
An epidemic of extreme respiratory deterrence, pneumonia and shortness of breath, the
SARS-CoV-2 viral infection began in Wuhan, Hubei Province, China in December 2019, and …
SARS-CoV-2 viral infection began in Wuhan, Hubei Province, China in December 2019, and …
[HTML][HTML] Current treatment in COVID-19 disease: a rapid review
M Rodriguez-Guerra, P Jadhav, TJ Vittorio - Drugs in context, 2021 - ncbi.nlm.nih.gov
The world has faced the most challenging pandemic of the modern era, that of severe acute
respiratory syndrome coronavirus 2 infection, causing coronavirus disease and affecting …
respiratory syndrome coronavirus 2 infection, causing coronavirus disease and affecting …
[HTML][HTML] Recent advances in management of COVID-19: A review
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing
significant mortality and economic consequences all over the globe. As of today, there are …
significant mortality and economic consequences all over the globe. As of today, there are …
[HTML][HTML] Current COVID-19 treatments: Rapid review of the literature
Y Dong, A Shamsuddin, H Campbell… - Journal of Global …, 2021 - ncbi.nlm.nih.gov
Background As SARS-CoV-2 continues to spread worldwide, it has already resulted in over
110 million cases and 2.5 million deaths. Currently, there are no effective COVID-19 …
110 million cases and 2.5 million deaths. Currently, there are no effective COVID-19 …
COVID-19: Therapeutics and interventions currently under consideration
RB McFee - Disease-a-Month, 2020 - Elsevier
With the emergence of COVID-19 extensive research began to identify medications,
candidate compounds and other therapeutic approaches. The complex virology of COVID …
candidate compounds and other therapeutic approaches. The complex virology of COVID …
A comprehensive updated review on SARS‐CoV‐2 and COVID‐19
YR Ren, A Golding, A Sorbello, P Ji… - The Journal of …, 2020 - Wiley Online Library
This literature review aims to provide a comprehensive current summary of the
pathogenesis, clinical features, disease course, host immune responses, and current …
pathogenesis, clinical features, disease course, host immune responses, and current …
Drugs for COVID-19: An update
J Ceramella, D Iacopetta, MS Sinicropi, I Andreu… - Molecules, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …
[HTML][HTML] SARS-CoV-2: from the pathogenesis to potential anti-viral treatments
PK Zarandi, MR Zinatizadeh, M Zinatizadeh… - Biomedicine & …, 2021 - Elsevier
Introduction The world is witnessing the spread of one of the members of Coronaviruses
(CoVs) family, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the …
(CoVs) family, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the …